BeiGene, Ltd. Termination Agreements
4 Contracts & Agreements
- First Amendment to the Settlement and Termination Agreement, dated as of January 10, 2024, by and between the Registrant, BeiGene Switzerland GmbH, Bristol-Myers Squibb Company,... (Filed With SEC on February 26, 2024)
- Mutual Termination and Release Agreement, dated September 17, 2023, by and between BeiGene Switzerland GmbH and Novartis Pharma AG (Filed With SEC on November 9, 2023)
- Settlement and Termination Agreement, dated as of August 1, 2023, by and between the Registrant, BeiGene Switzerland GmbH, Bristol-Myers Squibb Company, Celgene Corporation,... (Filed With SEC on November 9, 2023)
- Mutual Termination and Release Agreement, dated July 10, 2023, by and between BeiGene Switzerland GmbH and Novartis Pharma AG (Filed With SEC on August 2, 2023)
